Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Favorable Lawsuit Ruling Sends These Chemical Companies Surging But Hedge Funds Are Keeping Their Distance

Page 1 of 2

According to a Bloomberg report, a jury has found E I Du Pont De Nemours And Co (NYSE:DD) liable for an Ohio woman’s kidney cancer after a toxic Teflon chemical was found in Ohio and West Virginia’s water. The jury awarded the woman $1.6 million in damages, although DuPont Co’s spinoff Chemours Co (NYSE:CC) will bear the ultimate cost as per the details of its spinoff. Shares of E I Du Pont De Nemours And Co are up by 1.41% while shares of Chemours Co are up by 8.01% in afternoon trading. Let’s take a closer look at the two chemical companies and examine hedge fund sentiment towards them. 


Why do we pay attention to hedge fund sentiment? Most investors ignore hedge funds’ moves because as a group their average net returns trailed the market since 2008 by a large margin. Unfortunately, most investors don’t realize that hedge funds are hedged and they also charge an arm and a leg, so they are likely to underperform the market in a bull market. We ignore their short positions and by imitating hedge funds’ stock picks independently, we don’t have to pay them a dime. Our research has shown that hedge funds’ long stock picks generate strong risk-adjusted returns. For instance, the 15 most popular small-cap stocks outperformed the S&P 500 Index by an average of 95 basis points per month in our back-tests spanning the 1999-2012 period. We have been tracking the performance of these stocks in real-time since the end of August 2012. After all, things change and we need to verify that back-test results aren’t just a statistical fluke. We weren’t proven wrong. These 15 stocks managed to return 118% over the last 36 months and outperformed the S&P 500 Index by 60 percentage points (see the details here).

Shares of E I Du Pont De Nemours And Co (NYSE:DD) and Chemours Co (NYSE:CC) are rallying because the jury didn’t award the woman punitive damages. The two chemical companies will appeal the verdict, as the companies don’t believe the Teflon chemical PFOA contributed to the woman’s health problems. The stakes are high, as the the Ohio woman’s lawsuit is the first of 3,500 lawsuits concerning the toxic chemical. Overall, analysts think Du Pont and Chemours dodged a bullet with the ruling and the case will ultimately be settled out of court. If successfully settled, the case could be a template for the other 3,500 lawsuits concerning PFOA.

Follow Dupont E I De Nemours & Co (NYSE:DD)
Trade (NYSE:DD) Now!

Shares of E I Du Pont De Nemours And Co are down by 19% and shares of Chemours Co are off by almost 60% year-to-date, partly because of investor concerns over the pending lawsuits. If the two chemical companies reach a global settlement with the plaintiffs, management of the two companies can focus on their core businesses and deliver value for their shareholders. Du Pont can focus on transforming itself into a bio-based industrial products and advanced materials company, while Chemours’ management can focus on either selling itself or growing its bottom line.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!